Clinical Trial Update: Protocolized Diuretic Strategy in Cardiorenal Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a protocolized diuretic strategy for cardiorenal failure was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Kidney Failure

Snippet

Sponsor: Kelly V. Liang, MD | Conditions: Cardiac Failure, Renal Failure | Phase 4 | Status: TERMINATED | Results posted: 2017-07-17